Cancer is the world's second-leading cause of death, and the involvement of microbes in a
range of diseases, including cancer, is well established. The gut microbiota is known to play …

Synthetic biology provides a new paradigm for life science research (“build to learn”) and
opens the future journey of biotechnology (“build to use”). Here, we discuss advances of …

Dynamic consortium of microbial communities (bacteria, fungi, protists, viruses, and
nematodes) colonizing multiple tissue types and coevolving conclusively with the host plant …

Pivotal work in recent years has cast light on the importance of the human microbiome in
maintenance of health and physiological response to drugs. It is now clear that …

Ischemic stroke (IS) remains a leading cause of death and long-term disability globally.
Several mechanisms including glutamate excitotoxicity, calcium overload …

Common variable immunodeficiency (CVID) is the most common symptomatic primary
antibody immunodeficiency, characterized by reduced serum levels of IgG, IgA, and/or IgM …

Over 150 drugs are currently recognised as being susceptible to metabolism or
bioaccumulation (together described as depletion) by gastrointestinal microorganisms; …

An organism's phenotypes and fitness often depend on the interactive effects of its genome
(G h⁢ o⁢ s⁢ t), microbiome (G m⁢ i⁢ c⁢ r⁢ o⁢ b⁢ e), and environment (E). These G× G, G× …

The world's coral reefs are threatened by the cumulative impacts of global climate change
and local stressors. Driven largely by a desire to understand the interactions between corals …

Many medications can negatively impact the bacteria residing in our gut, depleting
beneficial species, and causing adverse effects. To guide personalized pharmaceutical …